Se Jun Park
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations (NCT05876806) | Se Jun Park | 2023-06-20 |
Track Se Jun Park automatically
Every clearance here is in the API, with alerts when new ones post.